Duly Health and Care | AI Transformation Index
Duly is a structurally durable physician group business — clinical delivery requires licensure, physical presence, and infrastructure that AI cannot substi...

Overview
Duly Health and Care is a large, independent multi-specialty physician group in Chicagoland (~110 locations, 1,000+ physicians) that generates ~$880M in revenue primarily through fee-for-service reimbursement for clinical care, diagnostics, surgical procedures, and ancillary services.
Executive Summary
Duly is a structurally durable physician group business — clinical delivery requires licensure, physical presence, and infrastructure that AI cannot substitute, and regulatory barriers make AI-native entry effectively impossible. The AI opportunity is meaningful but targeted: the largest gains come from compressing the substantial administrative and revenue cycle burden that consumes clinician time and back-office headcount, areas where Duly has essentially no current AI capability and an outside catalyst could unlock real P&L improvement. This is a moderate-opportunity, high-durability profile — AI doesn't threaten the core business but offers genuine efficiency transformation in support functions, making it a solid operational AI play rather than a transformative AI story.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
65.7
Ciridae AI Score
Durability Rationale
Duly's durability is anchored in structural characteristics that AI cannot dissolve: physician licensure requirements, the physical and procedural nature of clinical care delivery, 110+ locations of built clinical infrastructure, and the regulatory moat of healthcare delivery that makes AI-native entry effectively impossible. The company is not a middleman — it IS the care delivery layer — which sharply limits disintermediation risk. The primary durability concern is competitive pressure from hospital systems with deeper capital, fee-for-service reimbursement compression under value-based care models, and modest profit pool migration at the low-acuity primary care margin toward virtual-first AI-enabled competitors. These are real pressures but they are structural to physician group economics broadly, not AI-specific substitution threats.
Opportunity Rationale
The AI opportunity for Duly is real but concentrated in support functions rather than the clinical core — ambient AI scribing to recapture physician time, AI-powered revenue cycle management to reduce billing leakage and prior authorization burden, and intelligent scheduling and triage to optimize clinic throughput. These applications touch a meaningful portion of total costs and can deliver substantial P&L improvements, particularly given Duly's minimal current AI sophistication and a small IT team that signals no internal capability to self-capture these gains. The transformation upside is bounded, however, because the core revenue engine — physicians delivering care — cannot be meaningfully multiplied by AI the way a cognitive-labor-only business can; physical capacity and physician supply remain the ceiling on growth.
Key Risks
Hospital system consolidation accelerates as competitors gain AI-powered operational advantages — if large health systems use AI to dramatically improve their employed physician group economics and patient experience, Duly's independent positioning becomes a disadvantage rather than a differentiator, compressing both volume and payer leverage.
Duly's financial pressures and retrenchment trajectory may mean the organization lacks the capital and organizational bandwidth to invest in AI transformation — the opportunity is real, but a distressed or capital-constrained operator may be unable to fund the implementation needed to capture it, leaving the gains on the table for better-capitalized competitors.
Company Overview
| Headquarters | Downers Grove, Illinois, USA |
| Products / Services | Primary care, Specialty care, Immediate care centers (10+ locations with walk-in availability), Virtual healthcare (telehealth visits), Clinical research and trials (including cancer care via the Brian Moran Cancer Institute), Lab services (25+ lab locations), Patient resources such as MyChart for managing appointments, prescriptions, test results, billing, and communication with providers |
PE / Ownership History
| Event | Details |
|---|---|
Divestiture of Surgery Center Stakes November 2024 | Duly Health and Care sold 26% stakes in both the Lombard and Westmont surgery centers to Surgery Partners for $87 million. |
Acquired by Ares Management August 15, 2017 | Ares Management invested $1.45 billion in DuPage Medical Group (now Duly Health and Care). The investment supported growth initiatives including population health, geographic expansion, and additional service offerings. The deal closed on August 15, 2017, and included Ares acquiring Summit Partners' stake in DMG Practice Management Solutions. |
Executives
| Name | Background |
|---|---|
Daniel G. Chief Executive Officer (CEO) | Daniel G. has extensive leadership experience, having served as a board member at Alliance Homecare for over 8 years and on the advisory board at Gryphon Investors for nearly 10 years. He is also a member of the Board of Advisors at Denison University for 10 years. He is a 6-time CEO and has contributed to Fortune and Wall Street Journal. |
Chase Hammon Chief Financial Officer (CFO) | Previously CFO at Springfield Clinic for nearly 3 years and at Bon Secours Mercy Health (Richmond) for over 2 years. Also held a senior executive role in business operations at UT Southwestern Medical Center for over 7 years. |
Paul Merrick Chief Physician Executive and Chairman | Former Chief Clinical Advisor for the City of Chicago for nearly 4 years, Advisor CEO at Council Capital for 4 years, and Chair of the Finance Committee at Illinois State Medical Society for over 4 years. |
John Porcelli President | Practicing physician with expertise in financial analysis, strategic planning, operations management, leadership, data analytics, and strategic partnerships. |
Kerri Balbone Chief Revenue Officer (CRO) | Former Chief Operating Officer at Health Net and UnitedHealthcare Community Plan of California Inc, with over 3 years in COO roles. Also served as Public Safety Commissioner for the City of West Hollywood. |
Ares Management